Investors

Vivione Biosciences Inc. is pleased to announce a new development relationship with Kirkegaard & Perry Laboratories, Inc.

FIND OUT MORE

Applications

Vivione Biosciences has applications of interest to the Food Safety, Industrial Microbiology, and Clinical Infectious Disease areas.

FIND OUT MORE

How it works

Co-developed with the FDA National Center for Toxicological Research, RAPID-B has some unique capabilities.

FIND OUT MORE

News Feed

FDA and Vivione Enter into a New Three-Year Cooperative Research and Development Agreement

Vivione Biosciences set for food safety breakthrough

Vivione Biosciences In Position for a Big Year

Vivione Biosciences Inc. is pleased to announce a new development relationship

Vivione Biosciences Inc. signs collaboration with University of Arkansas Department

PACEpartners Inc. Announces Name Change to Vivione Biosciences Inc.

PACEpartners Inc. Retains Investor Relations Firm and Settles Debt

PACEpartners Inc. Completes Qualifying Transaction and Resumes Trading

PACEpartners Inc. Announces Closing of its Qualifying Transaction

Number of U.S. Foodborne Illness Cases Stalled: CDC

E. Coli Fears Prompt Massive Frozen Food Recall